James Krellenstein

Started Global Health Strategies' decarbonization practice, focusing on nuclear and renewable energies. Led GHS Climate's efforts to reduce reliance on Russian enriched uranium.

Founded PrEP4All in 2018. Discovered US ownership of PrEP patents, headed a research team developing policy to use them to decrease barriers to access -- work covered globally in two dozen articles in leading publications Led the organization's COVID-19 and mpox responses. Helped rasie over \$1 million dollars to support programs and supervised the policy team.

Help iscovered key aspects of, and helped develop the legal theory of a multi-billion dollar HIV antitrust litigation. Served as the firm's expert on antiviral chemistry, FDA regulations, HIV drug market economics, and the scientific development of certain HIV drugs

Worked on TLR4/MD-2/CD14 signaling in murine systems. Perfected labs flow cytometry protocols for CD14 surface expression, as well as lab's qRT-PCR cloning procedures for cloning murine CD14 into a baculovirus expression system.

Worked on InsP3R Ca++ signaling in the Departments of Pharmacology and Cellular Molecular Physiology . Worked on western blotting, as well as bacterial cloning.

Worked in pathogenesis research in septic shock in the Department of Surgery.

Advanced Quantum Mechanics ("QM III"), Quantum Mechanics I/II, Analytical Mechanics, Optics, Chemistry I/II, Thermodynamics and Statistical Physics, Electromagnetic Theory I/II, Immunology (Graduate Level), Linear Algebra, Differential Equations, Molecular Biophysics, History of the Soviet Union